文献速递腹部介入US

提高肝硬化患者诊断准确性:一项针对2056例患者超声造影引导下活检的多中心综合分析

Improving diagnostic accuracy in cirrhotic patients: a comprehensive multicenter analysis of contrast-enhanced ultrasound-guided biopsy in a large cohort of 2056 patients.
PubMed 文献 · Radiol Med · 2025-07-01

这项前瞻性多中心研究纳入9家中国医院的2056例成人局灶性肝病变患者,评估超声引导下肝活检准确性的影响因素。总体准确诊断率为94.2%;2至3次穿刺准确率显著高于1次穿刺(95.1% vs 87.3%,P<0.001),与超过3次穿刺相当(95.1% vs 93.2%,P=0.408)。肝硬化患者中,CEUS引导下活检的准确诊断概率从88.3%(超声引导)提高至93.3%。

要点

  • 肝硬化患者行CEUS引导下活检的准确诊断概率为93.3%,高于超声引导的88.3%。
  • 非肝硬化患者行超声引导下活检的准确诊断概率为96.4%。
  • 2至3次穿刺准确率95.1%,显著高于1次穿刺的87.3%,与超过3次穿刺的93.2%无显著差异。

核心结论

  • CEUS引导下活检可提高肝硬化患者的诊断准确性,而超声引导下活检在非肝硬化患者中准确性很高。
  • 2至3次穿刺即可达到95%的准确性,更多穿刺未带来额外改善。

研究设计与样本

  • 前瞻性研究,纳入9家中国医院的2056例成人局灶性肝病变患者,共活检2056个病灶。
  • 采用多因素logistic回归分析影响因素,并以卡方自动交互检测法构建预测模型。

诊断标准与关键数值

  • 总体准确诊断率为94.2%。
  • 2至3次穿刺准确率为95.1%,1次穿刺为87.3%,超过3次穿刺为93.2%;2至3次 vs 1次 P<0.001,2至3次 vs 超过3次 P=0.408。
  • 准确诊断的独立预测因素包括:无肝硬化[2.428(1.457-3.741),P<0.001]、CEUS引导[1.899(1.288-2.801),P=0.001]、穿刺次数>1[1.775(1.103-2.855),P=0.018]。
  • 决策树模型显示:肝硬化患者CEUS引导下活检的准确诊断概率为93.3%,超声引导下为88.3%;非肝硬化患者超声引导下活检的准确诊断概率为96.4%;模型总体预测准确率为94.4%。

临床应用与阅片要点

  • 对肝硬化患者的局灶性肝病变,可考虑采用CEUS引导下活检以提高诊断准确性。
  • 非肝硬化患者采用超声引导下活检即可获得很高的诊断准确性。
  • 穿刺2至3次即可满足准确性需求,超过3次穿刺未见额外获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the factors influencing ultrasound-guided liver biopsy accuracy and develop a decision model for managing biopsy results.

MATERIALS AND METHODS: This prospective study enrolled 2056 adult patients with focal hepatic lesions from nine Chinese hospitals. Diagnostic accuracy was calculated, and variables were analyzed using multivariate logistic regression. A prediction model was constructed using chi-square automatic interaction detection.

RESULTS: This study enrolled 2056 participants (1297 men, 759 women; mean age, 67.8 ± 10.8 years) with 2056 biopsied lesions (mean ± standard deviation: 4.0 ± 2.8 cm; range 0.7-17.7 cm), and 94.2% were accurately diagnosed. Two to three biopsy passes were significantly more accurate than one pass (95.1% vs. 87.3%, P < 0.001) and comparable to the accuracy of > 3 passes (95.1% vs. 93.2%, P = 0.408). Independent predictors of accurate diagnoses included absence of cirrhosis [2.428 (1.457-3.741), P < 0.001], CEUS guidance [1.899 (1.288-2.801), P = 0.001], and number of biopsy passes > 1 [1.775 (1.103-2.855), P = 0.018]. The predictive decision tree model demonstrated that for cirrhotic patients who underwent CEUS-guided biopsy, the probability of an accurate diagnosis increased from 88.3% (when US-guided biopsy was used) to 93.3%. Conversely, in noncirrhotic patients undergoing US-guided biopsy, a diagnostic accuracy probability of 96.4% was observed. The overall prediction accuracy of the model was 94.4%.

CONCLUSION: CEUS-guided biopsy enhances diagnostic accuracy in cirrhotic patients, whereas US-guided biopsy is highly accurate in noncirrhotic patients. Two to three needle punctures are sufficient for 95% accuracy, with no additional improvement from more punctures.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Jiang B, Jing X, Wang Y, et al. Improving diagnostic accuracy in cirrhotic patients: a comprehensive multicenter analysis of contrast-enhanced ultrasound-guided biopsy in a large cohort of 2056 patients. Radiol Med. 2025. PMID: 40591197. doi:10.1007/s11547-025-02034-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。